2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
Continuing Education
Oral Oncolytics in Focus: Updates on New Approved Therapies
Best Suited For: Pharmacist, Pharmacy Technician
CE Credits: 1 hours
Related Topics: New Drug Approvals
Description
The purpose of this CE presentation is to provide updates in new oral oncolytic agents that were approved in 2024. The presentation will review the mechanism of action, indication, dosing, clinical trial, adverse events, and additional clinical pearls for vorasidenib, lazertinib, inavolisib, and revumenib.
Pricing
This activity does not require payment to register.
Login to Register for this Course
Register for the course and access course materials by logging into our learning management system.
This course has expired.
View our full list of NCODA courses or check the webinar recordings for more to discover.